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Objective: To determine differences in the levels of the cardiovascular risk factors, cigarette smoking, serum Iipids and 
blood pressure, between three groups of patients with different sites of lower limb atherosclerosis. 
Design: Cross-sectional survey of a consecutive s ries of patients with symptoms ofeither intermittent claudication or rest 
pain. 
Methods and materials: One hundred and ninety-two men and women who had undergone angiography were classified 
using the BoUinger scoring system into groups with predominantly aortoiliac, femoropopliteal or dual-site disease. History 
of cigarette smoking, serum cotinine, serum thiocyanate, total cholesterol and HDL cholesterol were estimated. Systolic and 
diastolic pressures were measured and the ankle brachial pressure index (ABPI) was calculated. 
Results: Eighty-five patients were classified as having femoropopliteal disease, 34 aortoiliac disease and 73 dual-site 
disease. After adjusting for age, sex and severity of disease, aortoiliac patients were significantly ounger (p ~ 0.001), more 
likely to be female and current smokers, and had the highest levels of diastolic blood pressure. Life time cigarette 
consumption (pack-years) and total cholesterol concentrations were highest in femoropopliteal disease. Patients with dual- 
site disease were more likely to have had a myocardial infarction and angina pectoris (p <_ 0.05). Systolic blood pressure was 
also highest in this group. 
Conclusion: Different levels of cardiovascular risk factors may predispose individuals to atherosclerosis at different sites 
in the lower limb. Large population studies would be required to delineate the risks more precisely. 
K~ Words: Lower limb atherosclerosis; Smoking; Lipids; Blood pressure; Angiography. 
Introduction 
Within the lower limb arteries, the distribution of 
atherosclerotic disease tends to be segmental and the 
vessels show marked differences in the prevalence of 
occlusion. Studies have reported that, in the majority 
of patients with intermittent claudication, the most 
common occlusion site is the superficial femoral 
artery, whereas severe disease is far less common in 
the abdominal aorta and iliac vessels. ~-4 A high 
percentage of patients may also demonstrate multi- 
segment disease. 4'5 
The reasons why atherosclerosis only occurs at 
certain sites is not clean It is possible that mechanical 
and haemodynamic factors may contribute to the 
localisation of disease by affecting endothelial biol- 
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ogy. 1'6 In vitro studies have shown that the endothe- 
lium is capable of altering both its structure and 
function in response to high shear stresses, resulting in 
the release of vasoactive substances and inflammatory 
mediators associated with atherosclerosis. 6 In addi- 
tion, there is some evidence that certain cardiovas- 
cular risk factors are associated with differing patterns 
of disease within the arterial tree. In one population 
surve~ cigarette smoking was found to be more 
strongly related to the risk of peripheral arterial 
disease than to coronary heart disease, independently 
of the severity of underlying atherosclerosis. 7 Current 
smoking and systolic blood pressure were both sig- 
nificantly associated with isolated femoropoptiteal 
and aortoiliac disease in another cross-sectional sur- 
vey. s Elevations in serum lipid levels may also 
influence the development of atherosclerosis at differ- 
ent sites. 9'1° However, some of these studies have 
relied on non-invasive techniques to assess peripheral 
arterial disease which detect perfusion effects rather 
1078-5884/96/030340 + 07 $12.00/0 © 1996 W. B. Saunders Company Ltd. 
Cardiovascular Risk Factors 341 
than the degree or site of stenoses within individual 
arteries. In this stud3~ we used angiography to 
evaluate the precise anatomical location of lesions and 
were thus able to make more valid comparisons of risk 
factors which might be associated with a particular 
site of disease. 
The purpose of this study was to determine any 
differences in the levels of the cardiovascular risk 
factors (total cholesterol HDL cholesterol, blood 
pressure and cigarette smoking) between three groups 
of patients with predominantly different sites of 
peripheral arterial disease. The three groups, which 
were identified by angiography, comprised those with 
predominantly femoropopliteal, aortoiliac and dual- 
site disease. The site and severity of atherosclerosis 
were graded using a p y scoring system develoed b 
Bollinger et al. n This allowed us to control for the 
severity of disease which may be a confounding factor 
in comparing risk factor differences at specific arterial 
sites. 
Methods 
Patient selection 
The study consisted of a cross-sectional survey of a 
consecutive series of 192 men and women with 
symptoms of either intermittent claudication or rest 
pain referred for angiography to the Royal Infirmary 
of Edinburgh. Twenty-one patients had undergone 
previous angioplasty. Patients who had had a pre- 
vious amputation, reconstructive surgery or had 
symptoms of gangrene or ulceration were excluded 
from the study. 
Patients were recruited and examined over a period 
of 13 months, between January 1992 and January 1993. 
They were selected prospectively from a list of 
patients undergoing radiological investigations for the 
forthcoming week. Most were admitted on the day 
before, or on the same day as, their procedure but 
were always examined prior to angiography. Each 
subject completed a questionnaire which included 
validated questions on smoking history and details on 
past medical history and current medication. The 
Edinburgh Claudication Questionnaire, a modified 
form of the WHO questionnaire on intermittent 
claudication, was also administered. ~2
A 25ml blood sample was taken using a 21G 
infusion set without tourniquet while the subject was 
recumbent. Blood pressure was taken supinely using a 
Hawksley random zero sphygmomanometer. Ankle 
systolic pressures were measured using a Doppler 
probe (Sonicaid, Chichester, U.K.) and the ankle 
brachial pressure index (ABPI), which is the ratio of 
ankle to brachial systolic pressure, was estimated. In 
the laborator34 serum thiocyanate was measured on a 
COBAS BIO centrifugal analyser. Serum cotinine was 
measured by gas-liquid chromatography based on the 
method of Feyerabend and Russell. .3 These two 
biochemical markers were used to validate self- 
reported levels of smoking consumption. Total choles- 
terol was measured on the BM Hitachi 704 analyser by 
the CHOD-PAP method using reagents upplied by 
Boehringer-Mannheim (BM). HDL cholesterol was 
also measured on the BM analyser after precipitation 
with heparin manganese. Measurement of triglycer- 
ides levels were not included because patients had not 
always fasted overnight. Haemostatic and rheological 
factors were also measured and the results will be 
presented in a separate paper. 
Angiographic technique and procedure 
The method used for investigating peripheral athero- 
sclerosis was percutaneous transfemoral catheterisa- 
tion, performed by a IGC system DF 3000 unit. 
Patients were required to fast for 4-6 h and anti- 
coagulant medication was discontinued to prevent 
excess bleeding and haematoma formation. The 
femoral artery approach was preferred if a femoral 
pulse could be detected in either leg. If not, entry into 
the brachial artery was used. Following injection of 10 
ml 1% solution of lidocaine, a guide wire was 
manoeuvred through the femoral and iliac arteries 
and into the abdominal aorta. Either a size 4 or size 5 
French Lodis pigtail catheter was then introduced 
which controlled the rate of injection of radio-opaque 
contrast medium, niopam 300 into the aorta. The 
guide-wire was then withdrawn. Injection of niopam 
triggered the filming mechanism which involved an 
automatic serial film change ~and a programmable 
moving table-top with syn.~onised kilovoltage. 
Exposure of the peripheral ~rt-eries was carried out by 
a stepping mechanism "Whereby the exposure was 
decreased by half as the filming proceeded sequen- 
tially down the lower limbs. At 80 KV, the pelvic 
arteries were filmed at 40mAs, the femoral arteries at 
20mAs, the calf arteries at 10mAs and the ankle 
arteries at 5mAs. The film exposure rate at the pelvis 
was 1 per second for 4 s, 1 per second for 3 s at the 
thigh, I per second for 4 s at the knee and I per second 
for 4 s below the knee. This procedure lasted approx- 
imately i h. The site of atherosclerosis was'assessed by
uni-planar images for each patient. Bi-planar views 
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with additional ateral projections could not be pro- 
vided by the Radiology department. 
The Bollinger scoring system 
A modified scoring system which was originally 
developed by Bollinger et aI. 11 was used to grade the 
location of disease in each segment; his is described in 
detail elsewhere. 14Briefly, the system consists of an 
additive score which summarises the total number 
and severity of all lesions within a segment by a single 
code number. Four categories of lesions are graded: (a) 
an occlusion (b) stenoses narrowing more than half the 
diameter of the lumen (c) stenoses narrowing the 
lumen by more than 25% but less than 50% (d) plaques 
narrowing the lumen by a maximum of 25%. The 
system was devised to differentiate between perceived 
clinical severity of disease because the overall additive 
score for plaques and stenoses i always lower than a 
single occlusion score. 
Definition of arterial segments 
A total of 13 segments were coded in each patient. 
Segments distal to the popliteal artery were not 
evaluated because of relatively poor visualisation of 
these arteries. Patients who had undergone angio- 
plasty prior to the present study had the affected 
artery graded from x-rays taken at that time. The 
segments coded were: (1) the distal 5cm of the 
abdominal aorta and the left and right sides of the 
following segments: (2) common iliac (beginning at 
the aortic bifurcation and ending at the origin of the 
internal iliac) (3) external iliac (4) internal iliac (from 
its origin to first branching) (5) profunda femoris (first 
15cm of its main descending branch) (6) superficial 
femoral and (7) popliteal artery. 
Classification of patients by site 
Patients were classified into three groups (femor- 
opopliteal, aortoiliac or dual-site) by assessing the 
additive scores of each of their 13 segments. If a 
segment was occluded in either group of aortoiliac or 
femoropopliteal segments, the patient was assigned to 
that group. If however, there were no occlusions 
present but the patient had at least one moderate to 
severe stenosis (additive score > 3) within one of the 
segment groups, the patient was classified into that 
group. A patient was considered to have dual-site 
disease if there were occlusions or stenoses > 3 in both 
femoropopliteal nd aortoiliac segments. 
Statistical analysis 
Data were analysed on the University of Edinburgh 
mainframe computer using the BMDP and SPSS-X 
statistical packages. Chi-square analysis was used to 
test for differences in categorical variables within each 
class of disease. 
Analysis of covariance was carried out with age and 
sex as covariates and then further adjusted for 
ischaemic heart disease (angina and previous myocar- 
dial infarction) and severity of disease (number of 
occlusions). The distributions of thiocyanate, cotinine 
and HDL cholesterol were highly positively skewed 
and were transformed by taking the natural loga- 
rithm. Lifetime smoking was modelled using pack- 
years (the average number of packs of 20 cigarettes 
per day multiplied by the number of years as a 
smoker). The distribution of pack-years was also 
skewed and so the square root of this variable was 
used to reduce the influence of a few heavy smokers. 
The definition of a smoking "deceiver" was any 
individual with a level of serum thiocyanate above 
63.7 ~zmol/1 and above 17.5 ng/ml for serum cotinine 
who had declared themselves to be a non-smoker. ~5 
Results 
A total of 144 men and 48 women, aged 37-81 years 
participated in the study. The mean overall age was 
63.5 years. 
Seventy-three patients (38%) were classified as 
having dual-site disease and of these, 32 were so 
classified due to the presence of occlusions within 
both the femoropopliteal and aortoiliac segments. 
Eight five (44%) patients were identified as having 
more disease in the superficial femoral, profunda or 
popliteal arteries compared to the aorta and iliac 
arteries and most (75) of these were grouped accord- 
ing to the criterion of occlusion rather than significant 
stenoses. The smallest group comprised 34 (18%) 
subjects who had predominantly more disease in the 
aorta and iliac vessels and of these, 28 were selected 
on the basis of occlusion in these segments. 
Table 1 shows the distribution of age, sex, clinical 
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Table 1. Age, sex, clinical findings and vascular diseases in patients by angiographic site of lower limb atherosclerosis 
Site of atherosderosis 
Aortoiliac (n--34) Femoropopliteal (n=85) Dual-site (n=73) p-value't 
Age and sex 
Mean years (S.E.) 56.60 (1.82) 65.55 (1.03) 64.98 (1.00) 
Men (%) 67.6 74.1 79.5 
Women (%) 32.4 25.9 20.5 I 
Clinical findings 
Intermittent claudication 2.9 12.0 14.1 
(Grade 1) (%) 
Intermittent daudication 61.8 62.7 53.5 
(Grade 2) (%) 
Rest pain (%) 35.3 25.3 32.4 
ABPI mean (s.e.) 0.60 (0.04) 0.53 (0.02) 0.56 (0.03) 
NS 
NS 
Vascular diseases 
Angina pectoris (%) 15.2 24.7 40.3 * 
Myocardial infarction (%) 12.1 23.8 33.8 * 
Stroke (%) 0 8.2 14.1 NS 
Diabetes mellitus (%) 5.9 10.6 12.3 NS 
t p-value for difference b tween classes based on chi-square analysis. 
Ns=Not significant. *p~0.05. ***p~0.001 
ABPI Ankle Brachial Pressure Index. s.E. Standard Error 
Intermittent claudication: Grade 1 pain on hills only: Grade 2pain on hills and flat. 
findings and vascular diseases in patients with differ- 
ing sites of lower limb atherosclerosis. Those with 
aortoiliac disease were significantly younger than 
patients from the other two groups (p ~ 0.001). There 
was a greater proportion of women in the aortoiliac 
group compared to either the femoropopliteal or dual- 
site group, and the aortoiliac group had relatively 
more rest pain and a slightly higher ABPI than the 
femoropopliteal group. The dual-site group showed 
more evidence of a history of angina pectoris and 
previous myocardial infarction (both p < 0.05) than the 
other groups which probably indicates a higher 
degree of generalised atherosclerosis. Angina pectoris 
and myocardial infarction occurred less frequently in 
the aortoiliac group than the femoropopliteal group. 
Likewise, stroke and diabetes mellitus were less 
common in the aortoiliac group. 
The percentage of patients receiving regular medi- 
cation in each group was also examined (data not 
shown). There were no differences in aspirin con- 
sumption or other anti-platelet drug intake across the 
three groups. Only two individuals took lipid-low- 
ering drugs although other patients with hyper- 
lipidaemia may have been advised to modify their 
diet. However, in keeping with the differences in 
coronary heart disease between the groups (Table 1), 
intake of anti-hypertensive medication was highest in 
the dual-site group, with 20.5% of patients taking 
these drugs compared to 11.8% in the femoropopliteal 
and 8.8% in the aortoiliac groups. 
Risk factor levels adjusted for age and sex by site of 
disease are presented in Table 2. Of the three groups, 
those with aortoiliac disease had the lowest levels of 
total cholesterol but the highest levels of HDL choles- 
terol. Systolic blood pressure was highest in those 
with dual-site disease and diastolic pressure was 
highest in the aortoiliac group. Smoking histories were 
similar except that the aortoiliac group had more 
current smokers and fewer ex-smokers than the other 
groups. Serum cotinine and serum thiocyanate l vels 
were also higher in the aortoiliac patients, reflecting 
the greater percentage of current smokers in that 
group. Pack-year levels were slightly higher for 
patients with femoropopliteal disease than aortoiliac 
disease suggesting that the femoropopliteal patients 
may have smoked more heavily and/or  begun smok- 
ing at an earlier age. 
Further adjustment for the overall severity of 
atherosclerotic disease (measured by the prevalence of 
ischaemic heart disease and the number of occlusions 
in each group) had very little effect on the levels of risk 
factors measured in each patient group. For example, 
Fig. 1 shows that the aortoiliac group still had higher 
levels of serum thiocyanate and cotinine suggesting 
that the higher levels of current smoking were not 
simply related to the younger age of patients in this 
group. Similarly, there was no significant effect on risk 
factor levels when adjusted for the number of stenoses 
with an additive score > 3 in any of the three groups 
(data not shown). 
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Table 2. Serum lipids, blood pressure and smoking status adjusted for age and sex by angiographic site of lower limb atherosclerosis 
Site of atherosclerosis 
Aortoiliac (n=34) Femoropopliteal (n=85) Dual-site (n=73) 
Serum lipids (mmol/l) 
Total Cholesterol* 5.75 (0.25) 6.08 (0.14) 6.04 (0.15) 
HDL Cholesterolt 1.27 (1.13, 1.43) 1.23 (1.15, 1.32) 1.14 (1.06, 1.22) 
Blood pressure (mmHg) 
Systolic* 148.65 (4.78) 148.08 (2.90) 152.39 (3.12) 
Diastolic* 79.83 (2.76) 75.99 (1.68) 76.77 (1.82) 
Cigarette smoking 
Current Smoker (%) 44.1 25.9 31.5 
Ex Smoker (%) 41.2 58.8 57.5 
Never Smoker (%) 2.9 4.7 1.4 
Deceiver:~ (%) 11.8 10.6 9.6 
Serum Thiocyanate 0zmol/1)t 64.06 (51.45, 79.76) 54.36 (47.77, 61.85) 54.47 (46.91, 63.11) 
Serum Cotinine (ng/ml)t 34.01 (13.01, 88.93) 13.24 (7.58, 23.12) 16.40 (8.61, 31.24) 
Packyears (,/)* 2.07 (0.12) 2.30 (0.07) 2.25 (0.08) 
All p-values for differences between classes were non-significant at he 5% level. 
* Mean (S.E.). 
t Geometric Mean (transformed confidence intervals). Defined by levels above 63.7/~mol/1 forserum thiocyanate and 17.5 ng/ml for serum 
cotinine. 
Discussion 
In this study, we found that levels of the three main 
cardiovascular risk factors (blood pressure, serum 
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Fig. 1. Mean serum thiocyanate and cotinine concentrations i  the 
aortoiliac, femoropopliteal, nd dual-site groups, adjusted for age, 
sex, history of coronary heart disease, and number of lower limb 
arterial occlusions. 
lipids and cigarette smoking) varied in patients 
depending on the main site of peripheral athero- 
sclerosis. Although these differences were not statisti- 
cally significant, this may have been due to the small 
numbers of subjects, particularly in the aortoiliac 
group. The patients with aortoiliac disease were on 
average younger and more likely to be female and 
current smokers compared to the other two groups. In 
contrast, duration of smoking and higher levels of 
total cholesterol may be relatively more important in 
those with femoropopliteal disease. These two risk 
factors may also be thrombogenic since the femor- 
opopliteal patients demonstrated the highest number  
of occlusions per segment. Patients with dual-site 
disease had the highest levels of systolic blood 
pressure and the lowest levels of HDL cholesterol of 
any group. In addition, they were more likely to have 
a history of ischaemic heart disease, stroke and 
diabetes mellitus, suggesting a greater degree of 
generalised atherosclerosis. 
Although differences in the risk factor profile 
across the three groups could have been due to 
variation in overall severity of atherosclerosis, we 
found that adjusting for history of ischaemic heart 
disease and for the number  of occlusions or stenoses 
had little effect on the absolute levels of risk factors. 
It is therefore conceivable that different risk factor 
combinations or single risk factors may be selective 
in the initiation and/or  progression of peripheral 
atherosclerosis. 
The association between cigarette smoking and 
aortoiliac disease has been wel l -documented in other 
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clinical and autopsy studies. It has consistently been 
shown that the severity of aortic atherosclerosis 
increases both with numbers of cigarettes smoked and 
the duration of smoking. In addition, the angiographic 
studies have reported that smoking appears more 
strongly associated with aortic and iliac athero- 
sclerosis than with disease in the femoral vessels. 16-2° 
However, most of this early research ad methodo- 
logical limitations in that it did not allow for the 
possible confounding effects of other risk factors, nor 
did it adjust for underlying severity of disease. It also 
relied solely on self-reported cigarette smoking which 
is known to under-estimate rue levels of consump- 
tion. In the present study, we found that about 10% of 
self-declared non-smokers were probable smokers, 
based on cut-off points for serum cotinine and 
thiocyanate. 15
Why the aorta seems to be particularly vulnerable to 
the acute effects of cigarette smoking whereas, as the 
results of this study suggest, the femoropopliteal 
arteries to be more affected by a greater life-time 
exposure to smoking is not known. Reasons may be 
related to differences in wall composition or haemo- 
dynamics at these sites, differential responses to toxic 
smoke constituents or because of interactions with 
other risk factorsY -23 
Our results also indicated that raised systolic blood 
pressure appears to be more strongly related to diffuse 
(but less severe) disease within the lower limb arteries 
and that a raised diastolic pressure may predispose 
more to disease in the aortoiliac vessels. However, any 
relationship shown between blood pressure and site of 
disease should be interpreted with caution. Blood 
pressure may rise as a consequence of peripheral 
arterial disease, through increases in peripheral vas- 
cular resistance or because of a decrease in aortic 
compliance. 24Furthermore, the levels of blood pres- 
sure in this study are likely to be an underestimate of 
the true values because approximately 15% of all 
patients were receiving anti-hypertensive medication. 
Although considered to be a relatively weak risk 
factor for the development of intermittent claudica- 
tion, 2s-z7 elevated systolic pressure is the primary risk 
factor for ischaemic stroke 2s'29 and is also associated 
with the development of carotid arterial bruit and 
therefore does appear to have an effect on the site of 
atherosclerosis. However, we are unaware of any 
published data relating either systolic or diastolic 
blood pressure to a particular site of lower limb 
atherosclerosis. 
There is little conclusive vidence on the relation- 
ship between serum lipids and site of disease. Pre- 
vious reports have suggested that patients with 
coronary and peripheral atherosclerosis differ in the 
pattern of lipoprotein and apolipoprotein abnor- 
malities. 7'3°-32 Whereas elevated LDL cholesterol is 
particularly strongly associated with disease in the 
coronary arteries, hypertriglyceridaemia is considered 
to be relatively more pathogenic for peripheral athero- 
sclerosis, 3°'B~ although this may only be applicable for 
severe disease. 7 However, variation in levels of apoli- 
poproteins by site have been noted, including high 
levels of apopoprotein B in coronary artery disease 32 
and high levels of apolipoprotein Clll in patients with 
early carotid artery disease, z° 
The methodological limitations of this cross-sec- 
tional study should be considered. The study sample 
consists of a selected population of claudicants attend- 
ing hospital which may introduce bias. Also, it is 
probable that subjects with symptomatic disease 
change their lifestyle or undergo risk factor modifica- 
tion and thus their "true" levels may have changed. 
Furthermore, the differences in the risk factor profiles 
in patients with different sites of peripheral athero- 
sclerosis does not necessarily mean that the levels of 
the factors precede or are causally related to a site of 
disease, but may occur as a consequence of disease or 
from associations with other factors. The possibility of 
confounding by factors which we were unable to 
measure such as triglycerides, obesits~ alcohol con- 
sumption, menopausal status, and insulin resistance 
should also be considered. Another difficulty was that 
some overlap occurred in classifying the patients into 
groups because of the diffuse distribution of periph- 
eral atherosclerosis. Since only single plane angio- 
graphic views were available, which are known to 
underestimate disease, particularly in the profunda 
femoris and iliac arteries, 33'34 the true extent of disease 
may be also misrepresented. 
In conclusion, our results indicate that levels of 
cigarette smoking, blood pressure and serum lipids 
may vary depending on the site of lower limb arterial 
disease. Further studies are needed to find out 
whether any of these factors has an independent effect 
on the site of atherosclerosis while considering the 
effects of other possible risk factors. Epidemiological 
surveys are also required to confirm whether the 
observed relationships between risk factors and site of 
peripheral arterial disease occur in the general 
population. 
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